ADEs: Diabetes Agents Disclosures & Disclaimers

Policy on Disclosures to Learners

ODPHP strives to ensure balance, independence, objectivity, and scientific rigor in all of its educational programs. All planners, faculty members, moderators, discussants, panelists, and presenters participating in this program have been required to disclose any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of this program. This includes relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is to identify openly any conflict of interest so that attendees may form their own judgments about the presentation with full disclosure of the facts. In addition, faculty is expected to openly disclose any off-label, experimental, and/or investigational uses of drugs or devices in their presentation. Disclosures, Conflict of Interest (COI) and Resolution of COI policies are available.